- NEWS
Delaying a COVID vaccine’s second dose boosts immune response
A man in Tunis receives a dose of the Pfizer–BioNTech vaccine for COVID-19. Credit: Jdidi Wassim/SOPA Images/LightRocket via Getty
Facing a limited vaccine supply, the United Kingdom embarked on a bold public-health experiment at the end of 2020: delaying second doses of COVID-19 vaccines in a bid to maximize the number of people who would be at least partially protected from hospitalization and death.
Now, a study suggests that delaying the second dose of the Pfizer–BioNTech mRNA vaccine could boost antibody responses after the second inoculation more than threefold in those older than 801.
It is the first direct study of how such a delay affects coronavirus antibody levels, and could inform vaccine scheduling decisions in other countries, the authors say. “This study further supports a growing body of evidence that the approach taken in the UK for delaying that second dose has really paid off,” Gayatri Amirthalingam, an epidemiologist at Public Health England in London and a co-author of the preprint, said during a press briefing.
Many COVID-19 vaccines are given in two doses: the first initiates an immune response, and the second, ‘booster’ shot strengthens it. Clinical trials of the three vaccines used in the United Kingdom generally featured a three- to four-week gap between doses.
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
204,58 € per year
only 4,01 € per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-021-01299-y
References
Parry, H. M. et al. Preprint at medRxiv https://doi.org/10.1101/2021.05.15.21257017 (2021).
Pfizer COVID vaccine protects against worrying coronavirus variants
Could mixing COVID vaccines boost immune response?
The race to curb the spread of COVID vaccine disinformation
What it will take to vaccinate the world against COVID-19
Why Oxford’s positive COVID vaccine results are puzzling scientists